Four small-cap plays

Simon Thompson

Simon Thompson
Four small-cap plays

The directors of Aim-traded Kromek (KMK:33p), a supplier of patented core cadmium zinc telluride (CZT)-based radiation detection technologies to the medical, security and nuclear markets, were in buoyant mood during our results call, and with good reason.

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe to Investors Chronicle

Related topics

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now